Keyword Index

A

  • Affordability Availability and Affordability Of PET Tracers, The Challenges and Opportunities in Developing Countries [Volume 25, Issue 2, 2022, Pages 1-7]

D

  • Deauville Role of FDG/CT Scan Quantitative Analysis in Assessment of both Hodgkin and Non-Hodgkin lymphoma [Volume 25, Issue 2, 2022, Pages 15-29]
  • Devloping countries Availability and Affordability Of PET Tracers, The Challenges and Opportunities in Developing Countries [Volume 25, Issue 2, 2022, Pages 1-7]
  • Dosimetry Estimation of The Patient’s Specific Effective Dose for The Total Body F18- FDG PET/CT Scan, A Single Centre Experience [Volume 25, Issue 2, 2022, Pages 78-88]
  • DTC ASSESSMENT OF TREATMENT RESPONSE TO 131I THERAPY FOR PATIENTS WITH DIFFERENTIATED THYROID CARCINOMA IN THE PAST THREE YEARS (Single Institutional Experience) [Volume 25, Issue 2, 2022, Pages 45-62]
  • DTC Value of F-18 FDG PET/CT Compared to Conventional Imaging in changing management of Patients with Differentiated Thyroid Cancer before radioactive iodine ablation. [Volume 25, Issue 2, 2022, Pages 63-77]

E

  • Early breast cancer The correlation between 18F FDG PET CT metabolic parameters and pathological prognostic factors in early breast cancer patients [Volume 25, Issue 2, 2022, Pages 30-44]

L

  • Lugano Role of FDG/CT Scan Quantitative Analysis in Assessment of both Hodgkin and Non-Hodgkin lymphoma [Volume 25, Issue 2, 2022, Pages 15-29]

P

  • Patient weight Estimation of The Patient’s Specific Effective Dose for The Total Body F18- FDG PET/CT Scan, A Single Centre Experience [Volume 25, Issue 2, 2022, Pages 78-88]
  • PET-CT Availability and Affordability Of PET Tracers, The Challenges and Opportunities in Developing Countries [Volume 25, Issue 2, 2022, Pages 1-7]
  • PET/CT Value of F-18 FDG PET/CT Compared to Conventional Imaging in changing management of Patients with Differentiated Thyroid Cancer before radioactive iodine ablation. [Volume 25, Issue 2, 2022, Pages 63-77]
  • PET/CT Estimation of The Patient’s Specific Effective Dose for The Total Body F18- FDG PET/CT Scan, A Single Centre Experience [Volume 25, Issue 2, 2022, Pages 78-88]

R

  • RAI131 ASSESSMENT OF TREATMENT RESPONSE TO 131I THERAPY FOR PATIENTS WITH DIFFERENTIATED THYROID CARCINOMA IN THE PAST THREE YEARS (Single Institutional Experience) [Volume 25, Issue 2, 2022, Pages 45-62]
  • Response ASSESSMENT OF TREATMENT RESPONSE TO 131I THERAPY FOR PATIENTS WITH DIFFERENTIATED THYROID CARCINOMA IN THE PAST THREE YEARS (Single Institutional Experience) [Volume 25, Issue 2, 2022, Pages 45-62]

S

  • SUVmax Role of FDG/CT Scan Quantitative Analysis in Assessment of both Hodgkin and Non-Hodgkin lymphoma [Volume 25, Issue 2, 2022, Pages 15-29]

T

  • Treatment ASSESSMENT OF TREATMENT RESPONSE TO 131I THERAPY FOR PATIENTS WITH DIFFERENTIATED THYROID CARCINOMA IN THE PAST THREE YEARS (Single Institutional Experience) [Volume 25, Issue 2, 2022, Pages 45-62]